About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » Drugs » Drugs by Conditions » Drugs for Immune Checkpoint Inhibitors for Cancer Treatment

Medications and Drugs for Treatment of Immune Checkpoint Inhibitors for Cancer Treatment

Are you looking for effective medications to treat 'Immune Checkpoint Inhibitors for Cancer Treatment'? This page serves as your comprehensive resource hub, featuring the latest medications, both generic and brand-name, along with essential treatment options for Managing Immune Checkpoint Inhibitors for Cancer Treatment.

This page serves as an invaluable resource for both healthcare professionals and individuals seeking detailed information on various medication options to relieve Immune Checkpoint Inhibitors for Cancer Treatment effectively.

Click on a medication below to view details, including brand names, prices, dosages, side effects, and administration guidelines.

A FAQ section has been added for common medications, addressing popular customer inquiries that provides a deeper insight into its use for Immune Checkpoint Inhibitors for Cancer Treatment Management.

For accurate guidance, please consult your doctor to verify the information on this page or for any further questions you may have.

Immune Checkpoint Inhibitors for Cancer Treatment

Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has approved usage of these checkpoint proteins to treat Cancer.

Brand Names and Generic Names of Drugs for Treatment of Immune Checkpoint Inhibitors for Cancer Treatment

Atezolizumab

Atezolizumab is a programmed death ligand 1 (PD-L1) monoclonal antibody.

Avelumab

Avelumab is a programmed death ligand-1 (PD-L1) blocking antibody which is prescribed to treat adult and pediatric patients of 12 years and older who suffer from advanced Merkel-cell carcinoma that has spread to other parts of the body.

Cemiplimab-rwlc

Cemiplimab-rwlc is prescribed to treat cutaneous squamous skin cancer with tumors that are either locally advanced or that have moved to other body parts

Advertisement

Ipilimumab

Ipilimumab is a monoclonal antibody, prescribed for melanoma (a type of skin cancer).

Nivolumab

Nivolumab is a monoclonal antibody and a PD-1 inhibitor (programmed death receptor inhibitor) which is prescribed for cancer treatment.

Pembrolizumab

Pembrolizumab injection is prescribed to treat different types of cancer such as Melanoma or skin cancer, Non-Small-Cell lung cancer (NSCLC)...

Advertisement

Advertisement